Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the ...

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

Matthew Galsky, MD, discusses why some physicians were surprised at the positive outcomes of nivolumab trials in bladder ...

A mum from Hadleigh in Suffolk who discovered she had bladder cancer in a scan is to raise money for Cancer Research UK by ...

Some 10,000 Britons are diagnosed with bladder cancer every year, and experts warn the public is still unaware of the ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...